Statistically significant associations with NAFLD risk were found (but varied by populations) in 11 SNPs, including the rs738409 (PNPLA3), rs58542926 (TM6SF2), rs1260326 (GCKR), rs13118664 (HSD17B13), rs4808199 (GATAD2A), rs2954021 (TRIB2), rs4240624 (PPP1R3B), rs10883437 (CPN1), rs10883451 (ERLIN1), rs429358 (apolipoprotein E (APOE)), and rs641738 (MBOAT7)). Here, HSD17B13 is linked to metabolic dysfunction-associated steatotic liver disease.